<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>(-)-Epigallocatechin-3-gallate causes apoptosis — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>(-)-Epigallocatechin-3-gallate</strong>
  <span class="pred">&mdash;causes&rarr;</span>
  <strong>apoptosis</strong>
</div>
<div class="entity-id">CHEBI:4806 &nbsp;&middot;&nbsp; UNKNOWN:apoptosis</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: Curated (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 3.79<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (Curated, 1 paper)<br>Score from 9 citations: <strong>3.79</strong><br><span style="color:#888">4&times; supports (+2.29) &middot; 5&times; applies (+1.50)</span></div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.1016/j.taap.2020.115100">10.1016/j.taap.2020.115100</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 9 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:80px"></span><span>4</span><span class="cite-subtotal">&middot; +2.29</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">gut microbiome dysbiosis — causes → colorectal cancer</span><span class="cite-claim-weight">+0.79</span><a href="../claim/cf11c99c76911f6f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabolic gene expression — is_biomarker_for → colon cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/08b60bb877f4166d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">glucose metabolism pathway — correlates_with → colon cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/d078b1362d3898c5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Niclosamide ethanolamine salt-hydroxypropyl-β-cyclodextrin (NHC) — treats → Colon Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/288d70340fbdff4c.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:100px"></span><span>5</span><span class="cite-subtotal">&middot; +1.50</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">11-gene metabolic risk model — predicts → colon cancer prognosis</span><span class="cite-claim-weight">+0.30</span><a href="../claim/9242aa32df462172.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">11-gene metabolic risk model — distinguishes → colon cancer high-risk vs low-risk patients</span><span class="cite-claim-weight">+0.30</span><a href="../claim/e1e3f689b134d222.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lipid metabolism pathway — correlates_with → colon cancer</span><span class="cite-claim-weight">+0.30</span><a href="../claim/e4f76b1298b33e76.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">gut microbiome dysbiosis — causes → breast cancer</span><span class="cite-claim-weight">+0.30</span><a href="../claim/191b2acfbee8102f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Niclosamide ethanolamine salt (NES) — treats → Colon Cancer</span><span class="cite-claim-weight">+0.30</span><a href="../claim/41eacd01be323057.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>f450cb5afb086188</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/CHEBI:4806">CHEBI:4806</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/UNKNOWN:apoptosis">UNKNOWN:apoptosis</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
